Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7408 p36
8 July 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Emergency hormonal contraception prices fall with reduction in VAT

The price of emergency hormonal contraception (EHC) is set to drop by around £3, after the Government’s promised VAT reduction came into effect last weekend. Following talks with community pharmacies and sexual health charities, the HM Treasury announced the change, which cuts VAT on condoms, EHC and other contraceptives to 5 per cent.

The move, a commitment of the March budget (PJ, 25 March, p339), is part of a larger strategy, says the Government, to improve the nation’s sexual health and prevent sexually transmitted infections. Condoms, which, according to the Treasury, make up around 99 per cent of contraceptive sales, will cost around 30p less for a packet of three.

Superdrug began campaigning in 2005 to have VAT reduced on condom sales.The campaign included the delivery of 19,000 condoms to the steps of the Treasury last year.

Sid Dajani, chairman of the Royal Pharmaceutical Society practice committee, commented: “We hope that more affordable contraception will mean even more people will be able to practise safer sex and to visit their pharmacy where they can gain expert advice on issues also relating to sexual health and wellbeing.”

Sun care products

Calls to remove VAT from sun care products in next year’s budget are gaining momentum. A cross-party House of Commons motion has urged Chancellor Gordon Brown to reclassify sun blocks as essential health care items.Tabled by Bob Spink (Con, Castle Point), the motion was also sponsored by Liberal Democrat Bob Russell (Colchester) and Northern Ireland MP Mark Durkan (SDLP, Foyle). Their move follows similar demands from Superdrug and the Institute of Cancer Research.A Treasury official said that there are no plans to scrap or reduce VAT on such products, although classification of essential health care items is under constant review.

Back to Top


©The Pharmaceutical Journal